Car T Global Week
Advancing the Development of Safe and Affordable CAR-T Therapies

Name: Car T Global Week
Start: 2021-01-25
End: 2021-01-28

January 25-27, 2021 | Live Virtual Forum (EST)

View Program

Vendor Registration

Free Registration

Featured Speakers

Anne Chew

Executive Deputy Director, Center for Cellular Immunotherapies

University of Pennsylvania- Penn Medicine

Paul Rennert

CSO

Aleta BioTherapeutics

Chris Heery MD

CMO

Precision Biosciences

Cameron Durrant MD

CEO

Humanigen

Peter Marks MD, PhD

Director, Center for Biologics Evaluation and Research (CBER)

Food and Drug Administration (FDA)

Tal Salz PhD

Cell and Gene Therapy Reviewer, Office of Tissues and Advanced Therapies Division of Cellular and Gene Therapies

Food and Drug Administration (FDA)/CBER

Dan Bright

Director Of Manufacturing Operations

Cellectis

Shana Hardy

Biologist, Office of Tissues and Advanced Therapies Division of Clinical Evaluation and Pharm/Tox

FDA/CBER

John Tomtishen

Director of Manufacturing, Technical Operations

Legend Biotech

Steve Kanner

CSO

Caribou Biosciences

James Trager

CSO

Nkarta Therapeutics

Yan Chen

President & CEO

Elpis Biopharmaceuticals

Sean Werner

President

Sexton Biotechnologies

Ken Warrington

Sr. Director, Business Development

GenScript ProBio

Andrew Brown PhD

Strategy & Architecture Manager

ZS Associates

View All Speakers

Join strategic leaders to tackle the biggest obstacles in CAR T development. Have an opportunity to connect with key decision makers and multiple stakeholders in CAR T Cell Therapies. Starting with discovery and early stage strategies, participants traverse the current landscape including translation, clinical trials, manufacturing, and global markets.

Interactive group discussions with dedicated Q&A sessions will look at: